Coronaviruses
A section of Viruses (ISSN 1999-4915).
Section Information
-coronavirus
-HCoV-OC43
-HCoV-229E
-HCoV-NL63
-HKU1
-SARS-CoV
-MERS-CoV
-MHV
-TGEV
-reverse genetics
-innate immunity
-adaptive immunity
-virus-host interactions
-antivirals
-vaccines
-inactivated vaccines
-live-attenuated vaccines
-reporter viruses
-animal models
-HCoV-OC43
-HCoV-229E
-HCoV-NL63
-HKU1
-SARS-CoV
-MERS-CoV
-MHV
-TGEV
-reverse genetics
-innate immunity
-adaptive immunity
-virus-host interactions
-antivirals
-vaccines
-inactivated vaccines
-live-attenuated vaccines
-reporter viruses
-animal models
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- mRNA Vaccines (Deadline: 29 November 2024)
- Emerging Concepts in SARS-CoV-2 Biology and Pathology 2.0 (Deadline: 20 December 2024)
- Evaluation of COVID-19 Booster Vaccine Effects (Deadline: 31 December 2024)
- Multiple Hosts of SARS-CoV-2: Second Volume (Deadline: 31 December 2024)
- Aging and Comorbidities of COVID-19 2024 (Deadline: 31 December 2024)
- COVID-19 and Pneumonia 3rd Edition (Deadline: 31 December 2024)
- Coronaviruses and Influenza Viruses: Evolution, Cross-Species Transmission, and Recombination (Deadline: 31 December 2024)
- Coronaviruses Pathogenesis, Immunity, and Antivirals (Deadline: 25 January 2025)
- Molecular Epidemiology of SARS-CoV-2, 3rd Edition (Deadline: 31 January 2025)
- SARS-CoV-2 Variants, Vaccines, and Immune Responses (Deadline: 31 January 2025)
- Impact of Co-infections in COVID-19: Predisposing Mechanisms and Interplay between Invasive Viral, Bacterial and Fungal Pathogens (Deadline: 20 February 2025)
- Emerging Variants of SARS-CoV-2 (Deadline: 31 March 2025)
- COVID-19 Complications and Co-infections (Deadline: 31 July 2025)
- SARS-CoV-2 Neutralizing Antibodies 3rd Edition (Deadline: 31 July 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
- Coronaviruses (Closed)
